Low-density lipoprotein: a versatile nanoscale platform for targeted delivery

Luyao Dai; Shuaijun Li; Qian Hao; Ruina Zhou; Hui Zhou; Wenxi Lei; Huafeng Kang; Hao Wu; Yuanpei Li; Xiaobin Ma

doi:10.1039/d2na00883a

journal article Open Access Jan 01, 2023

Low-density lipoprotein: a versatile nanoscale platform for targeted delivery

Luyao Dai

Shuaijun Li Qian Hao Ruina Zhou Hui Zhou

Wenxi Lei Huafeng Kang Hao Wu

Yuanpei Li

Xiaobin Ma

Nanoscale Advances Vol. 5 No. 4 pp. 1011-1022 · Royal Society of Chemistry (RSC)

View at Publisher Save 10.1039/d2na00883a

Abstract

This review introduces low-density lipoprotein (LDL) delivery systems, summarizes the research status and progress in targeted diagnosis and therapy, and looks forward to the clinical application of LDL as an effective delivery vehicle.

Topics

No keywords indexed for this article. Browse by subject →

References

144

[1]

Lu Biomaterials (2022) 10.1016/j.biomaterials.2022.121852

[2]

Raj Semin. Cancer Biol. (2021) 10.1016/j.semcancer.2019.11.002

[3]

Wu Adv. Mater. (2020) 10.1002/adma.201903759

[4]

Hu Chem. Rev. (2019) 10.1021/acs.chemrev.7b00663

[5]

Min Chem. Rev. (2015) 10.1021/acs.chemrev.5b00116

[6]

Cortajarena Nanobiomedicine (2014) 10.5772/58841

[7]

Doxil® — The first FDA-approved nano-drug: Lessons learned

Yechezkel (Chezy) Barenholz

Journal of Controlled Release 2012 10.1016/j.jconrel.2012.03.020

[8]

Hua Front. Pharmacol. (2015) 10.3389/fphar.2015.00219

[9]

Challenges in Development of Nanoparticle-Based Therapeutics

Neil Desai

The AAPS Journal 2012 10.1208/s12248-012-9339-4

[10]

Crist Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. (2021)

[11]

Ng Acc. Chem. Res. (2011) 10.1021/ar200017e

[12]

Fredrickson Circulation (1993) 10.1161/01.cir.87.1.1

[13]

Chung Adv. Drug Delivery Rev. (2004) 10.1016/j.addr.2003.12.003

[14]

Huang Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. (2015)

[15]

Zhang J. Lipid Res. (2011) 10.1194/jlr.d010959

[16]

Zheng Proc. Natl. Acad. Sci. U. S. A. (2005) 10.1073/pnas.0508677102

[17]

Zhu Angew. Chem., Int. Ed. (2017) 10.1002/anie.201704674

[18]

Wasan J. Pharm. Sci. (1998) 10.1021/js970407a

[19]

Drug delivery and nanoparticles: Applications and hazards

de Jong

International Journal of Nanomedicine 2008 10.2147/ijn.s596

[20]

Skajaa Arterioscler., Thromb., Vasc. Biol. (2010) 10.1161/atvbaha.108.179275

[21]

McMahon Cancer Treat. Res. (2015) 10.1007/978-3-319-16555-4_6

[22]

Kuai ACS Nano (2016) 10.1021/acsnano.5b07522

[23]

Raut Ther. Delivery (2018) 10.4155/tde-2017-0122

[24]

Gianazza Mass Spectrom. Rev. (2021) 10.1002/mas.21747

[25]

Krishna ACS Chem. Neurosci. (2020) 10.1021/acschemneuro.0c00430

[26]

Alanazi Pharm. Res. (2004) 10.1023/b:pham.0000022415.74531.d9

[27]

Nikanjam Int. J. Pharm. (2007) 10.1016/j.ijpharm.2006.07.046

[28]

Allijn ACS Nano (2013) 10.1021/nn403258w

[29]

Teemu Soft Matter (2011) 10.1039/c1sm05367a

[30]

P. E.Fielding and C. J.Fielding , in New Comprehensive Biochemistry , Elsevier , 2002 , vol. 36 , pp. 527–552

[31]

Harisa Saudi Pharm. J. (2014) 10.1016/j.jsps.2013.12.015

[32]

Muntoni Nutr., Metab. Cardiovasc. Dis. (2009) 10.1016/j.numecd.2008.06.002

[33]

Moschovi J. Pediatr. Hematol./Oncol. (2004) 10.1097/00043426-200405000-00006

[34]

Niendorf Int. J. Cancer (1995) 10.1002/ijc.2910610405

[35]

Vitols Lancet (1985) 10.1016/s0140-6736(85)92679-0

[36]

Firestone Bioconjugate Chem. (1994) 10.1021/bc00026a002

[37]

Crich Neoplasia (2007) 10.1593/neo.07682

[38]

Xu Adv. Drug Delivery Rev. (2013) 10.1016/j.addr.2012.09.041

[39]

Anupriya J. Nanopart. Res. (2013) 10.1007/s11051-013-1888-7

[40]

Angelin J. Clin. Invest. (1983) 10.1172/jci110835

[41]

Hynds Biochim. Biophys. Acta (1984) 10.1016/0005-2760(84)90189-9

[42]

Spady Proc. Natl. Acad. Sci. U. S. A. (1985) 10.1073/pnas.82.13.4526

[43]

Pitas J. Cell Biol. (1985) 10.1083/jcb.100.1.103

[44]

Leitersdorf Biochim. Biophys. Acta (1985) 10.1016/0005-2760(85)90272-3

[45]

Chen J. Am. Chem. Soc. (2007) 10.1021/ja069336k

[46]

Glickson Adv. Exp. Med. Biol. (2009) 10.1007/978-0-387-85998-9_35

[47]

Nykjaer Trends Cell Biol. (2002) 10.1016/s0962-8924(02)02282-1

[48]

Willnow Nat. Cell Biol. (1999) 10.1038/14109

[49]

Brown Science (1986) 10.1126/science.3513311

[50]

Krieger J. Supramol. Struct. (1979) 10.1002/jss.400100409

Showing 50 of 144 references

Metrics

13

Citations

144

References

Details

Published: Jan 01, 2023
Vol/Issue: 5(4)
Pages: 1011-1022
License: View

Authors

L

Luyao Dai

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

S

Shuaijun Li

Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

Q

Qian Hao

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

R

Ruina Zhou

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

H

Hui Zhou

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

W

Wenxi Lei

Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

H

Huafeng Kang

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China

H

Hao Wu

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China; Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA; Department of Biophysics, School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, China

Y

Yuanpei Li

Department of Biochemistry and Molecular Medicine, UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, CA 95817, USA

X

Xiaobin Ma

Department of Oncology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China

Funding

National Natural Science Foundation of China Award: 52203186

Natural Science Foundation of Shaanxi Provincial Department of Education Award: 2022KW-01

Cite This Article

Luyao Dai, Shuaijun Li, Qian Hao, et al. (2023). Low-density lipoprotein: a versatile nanoscale platform for targeted delivery. Nanoscale Advances, 5(4), 1011-1022. https://doi.org/10.1039/d2na00883a

Low-density lipoprotein: a versatile nanoscale platform for targeted delivery

You May Also Like